Athersys Inc ATHX:NASDAQ

Last Price$0.22Cboe Real-Time Last Sale as of 12:00PM ET 8/17/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.02(8.33%)
Bid (Size)$0.22 (100)
Ask (Size)$0.22 (3,900)
Day Low / High$0.22 - 0.24
Volume3.8 M

View Biotechnology IndustryPeer Comparison as of 08/17/2022


Athersys Inc ( NASDAQ )

Price: $0.22
Change: -0.02 (8.33%)
Volume: 3.8 M
12:00PM ET 8/17/2022

Avalon Globocare Corp ( NASDAQ )

Price: $0.67
Change: -0.02 (3.46%)
Volume: 37.0 K
11:32AM ET 8/17/2022

Harpoon Therapeutics Inc ( NASDAQ )

Price: $2.12
Change: +0.01 (0.47%)
Volume: 107.0 K
11:41AM ET 8/17/2022

ImmuCell Corp ( NASDAQ )

Price: $7.85
Change: 0.00 (0.00%)
Volume: 2.5 K
3:59PM ET 8/16/2022

Syros Pharmaceuticals Inc ( NASDAQ )

Price: $0.95
Change: -0.02 (2.06%)
Volume: 130.9 K
11:51AM ET 8/17/2022

Read more news Recent News

Athersys Signs $12 Million Registered Direct Offering
9:07AM ET 8/15/2022 MT Newswires

Athersys (ATHX) said Monday that a health care investor has agreed to purchase 48 million shares of the company's common stock at $0.25 per share in a...

-- Earnings Flash (ATHX) ATHERSYS Posts Q2 Revenue $2.3M
4:17PM ET 8/11/2022 MT Newswires


Athersys Says Equity Purchase Deal With Aspire Capital Fund Has Been Terminated
7:59AM ET 7/08/2022 MT Newswires

Athersys (ATHX) said Friday that Aspire Capital Fund has terminated their equity purchase agreement on July 6. Athersys said it is currently evaluating...

Wall Street Set to Open Higher
9:16AM ET 6/17/2022 MT Newswires

US stocks look set to open Friday trading higher as Federal Reserve Chairman Jerome Powell speaks before the inaugural Conference on the International...

View all Commentary and Analysis

Athersys, Inc. (ATHX) CEO Daniel Camardo on Q2 2022 Results - Earnings Call Transcript
11:07PM ET 8/11/2022 Seeking Alpha

Athersys: Dead Man Walking
4:29PM ET 7/25/2022 Seeking Alpha

Athersys (ATHX) Investor Presentation Treasure Data - Slideshow
1:31PM ET 5/26/2022 Seeking Alpha

Athersys: Focus On Stroke
9:40AM ET 5/04/2022 Seeking Alpha

Company Profile

Business DescriptionAthersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. View company web site for more details
Address3201 Carnegie Avenue
Cleveland, Ohio 44115-2634
Number of Employees75
Recent SEC Filing08/17/2022424B5
CEO, Co-CFO, Secretary, Director & CAODaniel A. Camardo
Chief Operating OfficerMaia A. Hansen
Chief Financial OfficerKasey Rosado
Head-Information Technology & CommunicationsRakesh Ramachandran

Company Highlights

Price Open$0.24
Previous Close$0.24
52 Week Range$0.17 - 1.81
Market Capitalization$60.5 M
Shares Outstanding275.1 M
SectorHealth Technology
Next Earnings Announcement11/21/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.32
Beta vs. S&P 500N/A
Revenue$24.3 M
Net Profit Margin-993.97%
Return on Equity-434.69%

Analyst Ratings as of 08/16/2022

Consensus RecommendationConsensus Icon
Powered by Factset